LAVA Therapeutics NV
NASDAQ:LVTX
LAVA Therapeutics NV
NASDAQ:LVTX
Price:
3.03 USD
-2.26%
Market Closed
Updated:
May 4, 2024
LAVA Therapeutics NV
Cash from Investing Activities
|
LAVA Therapeutics NV
Cash from Investing Activities Peer Comparison
Comparables:
PHARM
QURE
ARGX
MRUS
N
NAMS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LAVA Therapeutics NV
NASDAQ:LVTX
|
Cash from Investing Activities
-$17.6m
|
CAGR 3-Years
-228%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharming Group NV
AEX:PHARM
|
Cash from Investing Activities
-$129.4m
|
CAGR 3-Years
-102%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
|
Uniqure NV
NASDAQ:QURE
|
Cash from Investing Activities
-$205.7m
|
CAGR 3-Years
-179%
|
CAGR 5-Years
-118%
|
CAGR 10-Years
-39%
|
|
|
argenx SE
XBRU:ARGX
|
Cash from Investing Activities
$308.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merus NV
NASDAQ:MRUS
|
Cash from Investing Activities
-$27m
|
CAGR 3-Years
-163%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Cash from Investing Activities
€715k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LAVA Therapeutics NV's Cash from Investing Activities?
Cash from Investing Activities
-17.6m
USD
-17.6m
USD
Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Cash from Investing Activities amounts to -17.6m USD.
What is LAVA Therapeutics NV's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-228%
-228%
The average annual Cash from Investing Activities growth rates for LAVA Therapeutics NV have been -228% over the past three years .
You don't have any saved screeners yet
